SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug. (Q46248926)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jeffrey C Glennon

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Andrew C McCreary

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Charles R Ashby

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Herbert Y Meltzer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Zhu Li

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jan-Hendrik Reinders

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Mayke B Hesselink

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Stephen K Long

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Arnoud H Herremans

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Herman van Stuivenberg

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Rolf W Feenstra

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Chris G Kruse

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

0 references

publication date

17 May 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Neuropsychopharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

78-94

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710314%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301098

0 references

Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Selective activation of 5HT1A receptors induces lower lip retraction in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Heterogeneity of [3H]-mepyramine binding sites in guinea pig cerebellum and lung.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The hippocampus, memory, and place cells: is it spatial memory or a memory space?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Human declarative memory formation: segregating rhinal and hippocampal contributions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Cloning of the cDNA and gene for a human D2 dopamine receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Serotonergic and histaminergic mechanisms involved in intralipid drinking?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Dopamine D3 receptor antagonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Characterization of the human dopamine D3 receptor expressed in transfected cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

A highly sensitive adenylate cyclase assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Multiple dopamine D4 receptor variants in the human population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Corticotropin-peptide regulation of intracellular cyclic AMP production in cortical neurons in primary culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Decreased 5-HT1A receptor binding in amygdala of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

21 January 2018

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

7 January 2021

based on heuristic

inferred from DOI database lookup

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

7 January 2021

based on heuristic

inferred from DOI database lookup

The cortical dopamine system: role in memory and cognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301098

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46248926&oldid=1466202655"